SCHEMBL13601554

SCHEMBL13601554

CCOC(=O)OC(C)OC(=O)C1CCN(C)CC1

nearest known ligand 0.46

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.46
ALDH1A1 P00352 5/20 0.41
GAA P10253 3/20 0.41
KDM4E B2RXH2 2/20 0.39
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
LIPE Q05469 1/20 0.38
PKM P14618 1/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12774211 0.92 CHRM1 (0.46) MAPTALDH1A1GAAKDM4EKMT2A
SCHEMBL12772856 0.79 CHRM1 (0.44) MAPTALDH1A1GAAKDM4EKMT2A
SCHEMBL446501 0.79 MAPT (0.64) MAPTALDH1A1GAAKDM4EKMT2A
SCHEMBL917427 0.78 LMNA (0.41) MAPTALDH1A1GAAKDM4EKMT2A
SCHEMBL917430 0.78 LMNA (0.41) MAPTALDH1A1GAAKDM4EKMT2A
Iodide SCHEMBL30309834 0.77 MAPT (0.62) MAPTALDH1A1GAAKDM4EKMT2A
Hydrochloric Acid SCHEMBL27605420 0.77 MAPT (0.62) MAPTALDH1A1GAAKDM4EKMT2A
Hydrochloric Acid SCHEMBL9704969 0.77 MAPT (0.62) MAPTALDH1A1GAAKDM4EKMT2A
Hydrochloric Acid SCHEMBL5076170 0.77 LMNA (0.40) MAPTALDH1A1GAAKDM4EKMT2A
SCHEMBL9391569 0.77 MAPT (0.35) MAPTALDH1A1GAAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed